Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGAP22 intronic transcript 1 (ARHGAP22-IT1, also known as FLJ35752) is a human non-protein-coding RNA gene, classified as an intronic transcript from the ARHGAP22 locus[1][3][4][6]. There is currently no evidence of this RNA functioning as a receptor, enzyme, transporter, or other direct therapeutic target, and its biological role and disease associations have not been clearly defined in the scientific literature. Key clarifications: - ARHGAP22-IT1 is a long non-coding RNA (lncRNA), specifically an intronic transcript situated at the ARHGAP22 gene locus, and should not be confused with ARHGAP22, which is a protein-coding gene and a member of the Rho GTPase-activating protein family[2][9]. - There are no known drugs, mechanisms of action, or defined safety concerns for this transcript. - The biological function, disease relevance, and role as a biomarker remain poorly characterized at present[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARHGAP22 intronic transcript 1 (ARHGAP22-IT1).